Effect of Lavender syrup on COVID-19

Phase 3

Recruiting

• Conditions: Condition 1: COVID-19. Condition 2: COVID-19.; COVID-19, virus identified; COVID-19, virus not identified; U07.1; U07.2

• Registration Number: IRCT20110907007511N4
• Lead Sponsor: Gorgan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Age between 18 and 65 years
Conscious consent to participate in the study
Fever greater than 38 degrees or a feeling of hot flashes with at least one clinical sign of a dry cough, 24% number of breaths per minute, headache or body aches, feeling weak and lethargic, anosmia (olfactory disturbance) or taste disturbances, nausea
Seven days or less after the onset of symptoms at the first visit or relapse within 6 weeks of previous treatment
Absence of respiratory distress
Candidate for outpatient treatment

Exclusion Criteria

Need to be hospitalized
Pregnancy and lactation
Smoking
Underlying heart / liver /kidney disease / high blood pressure
Use other herbal medicines to control the symptoms of the disease
Sensitivity to lavender

Study & Design

• Study Type: interventional
• Study Design: Not specified